Statin Therapy In Patients With Vasospastic Angina

• Status: Withdrawn
• Trial end date: 2023-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate whether statin is effective in the treatment of vasospastic angina.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seung-Jung Park
• Collaborator: CardioVascular Research Foundation, Korea
• Treatments: Atorvastatin; Atorvastatin Calcium

Criteria

Inclusion Criteria:

• Age 19 and more

• Vasospastic angina

• LDL less than 160mg/dl

• Written consent

Exclusion Criteria:

• Coronary artery stenosis more than 50% or ischemic coronary disease

• History of percutaneous coronary intervention

• Cerebrovascular diseases or peripheral

• Dyslipidemia required statin therapy

• Heart failure, arrhythmogenic right ventricular dysplasia, hypertrophic cardiomyopathy, akinesia or aneurysm on left ventricular wall, anomaly of coronary artery

• NYHA III and IV

• Arrhythmia

• Primary cardiac electrical diseases

• Cardiac pacemaker or implantable defibrillator

• Pregnancy or breast feeding

• Life expectancy less than 2 years